157 related articles for article (PubMed ID: 27721000)
21. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).
Husain A; He G; Venkatraman ES; Spriggs DR
Cancer Res; 1998 Mar; 58(6):1120-3. PubMed ID: 9515792
[TBL] [Abstract][Full Text] [Related]
22. Extremely low frequency electromagnetic fields as effectors of cellular responses in vitro: possible immune cell activation.
Simkó M; Mattsson MO
J Cell Biochem; 2004 Sep; 93(1):83-92. PubMed ID: 15352165
[TBL] [Abstract][Full Text] [Related]
23. Non-homologous DNA end joining.
Pastwa E; Błasiak J
Acta Biochim Pol; 2003; 50(4):891-908. PubMed ID: 14739985
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer.
Hosoi Y; Watanabe T; Nakagawa K; Matsumoto Y; Enomoto A; Morita A; Nagawa H; Suzuki N
Int J Oncol; 2004 Aug; 25(2):461-8. PubMed ID: 15254745
[TBL] [Abstract][Full Text] [Related]
25. Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
Saleh EM; El-Awady RA; Anis N; El-Sharkawy N
Biomed Pharmacother; 2012 Oct; 66(7):554-62. PubMed ID: 22939736
[TBL] [Abstract][Full Text] [Related]
26. Extremely low-frequency electromagnetic fields induce neural differentiation in bone marrow derived mesenchymal stem cells.
Kim HJ; Jung J; Park JH; Kim JH; Ko KN; Kim CW
Exp Biol Med (Maywood); 2013 Aug; 238(8):923-31. PubMed ID: 23970408
[TBL] [Abstract][Full Text] [Related]
27. [Study on the expression of DNA excision repair biomarkers in cispatin-treated lung cancer cell line].
Wang ZY; Zhou S; Lu B; Zhang X; Hao QL; Zhou YK
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):109-11. PubMed ID: 12839662
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the genotoxic effects induced by 50 Hz extremely low-frequency electromagnetic fields and 1800 MHz radiofrequency electromagnetic fields in GC-2 cells.
Duan W; Liu C; Zhang L; He M; Xu S; Chen C; Pi H; Gao P; Zhang Y; Zhong M; Yu Z; Zhou Z
Radiat Res; 2015 Mar; 183(3):305-14. PubMed ID: 25688995
[TBL] [Abstract][Full Text] [Related]
30. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
Dees C; Garrett S; Henley D; Travis C
Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
[TBL] [Abstract][Full Text] [Related]
31. Examining the non-homologous repair process following cisplatin and radiation treatments.
Myint WK; Ng C; Raaphorst GP
Int J Radiat Biol; 2002 May; 78(5):417-24. PubMed ID: 12020431
[TBL] [Abstract][Full Text] [Related]
32. Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
Li X; Tian J; Bo Q; Li K; Wang H; Liu T; Li J
Tumour Biol; 2015 Dec; 36(12):9365-72. PubMed ID: 26108997
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
[TBL] [Abstract][Full Text] [Related]
34. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
Pavan S; Olivero M; Corà D; Di Renzo MF
Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
[TBL] [Abstract][Full Text] [Related]
35. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
36. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
37. Expression analysis of proteins involved in the non homologous end joining DNA repair mechanism, in the bone marrow of adult de novo myelodysplastic syndromes.
Economopoulou P; Pappa V; Kontsioti F; Papageorgiou S; Foukas P; Liakata E; Economopoulou C; Vassilatou D; Ioannidou ED; Chondropoulos S; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
Ann Hematol; 2010 Mar; 89(3):233-9. PubMed ID: 19727724
[TBL] [Abstract][Full Text] [Related]
38. Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line.
Antonini RA; Benfante R; Gotti C; Moretti M; Kuster N; Schuderer J; Clementi F; Fornasari D
Toxicol Lett; 2006 Jul; 164(3):268-77. PubMed ID: 16513298
[TBL] [Abstract][Full Text] [Related]
39. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
40. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV.
Kuhfittig-Kulle S; Feldmann E; Odersky A; Kuliczkowska A; Goedecke W; Eggert A; Pfeiffer P
Mutagenesis; 2007 May; 22(3):217-33. PubMed ID: 17347130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
